Blatchford Limited, Vandstrom, Inc., and Veryan Medical Limited, among others, are the major players in the global medical biomimetics market.
The global medical biomimetics market is expected to grow at a CAGR of about 5.2% in the forecast period of 2022-2027. As per the analysis by Expert Market Research, the market is expected to be driven by the growing geriatric population and rising rates of organ failure.
The global medical biomimetics market is being supported by the rising geriatric population and increasing organ failure rates. The surging adoption and preference for innovative biomimetic technologies and advancements in nanotechnology are likely to positively influence the market for medical biomimetics. As nanotechnology can demonstrate complex biomimetic behaviour while explaining single cells and molecules at high performance, it can lead to the development of personalised medical biomimetic solutions.
Various leading companies are increasingly investing in research activities to advance the development of high-precision medical biomimetics solutions. The potential of medical biomimetics to advance regenerative medicine, tissue engineering, and biomedical engineering, among others, is anticipated to augment the market development. In addition, the rising use of medical biomimetics to treat congenital disorders and various diseases is expected to aid the market growth in upcoming years.
In May 2022, Veryan Medical Limited was awarded a purchasing agreement for Biliary and Peripheral Stents with Premier, Inc., which would enable the availability of the BioMimics 3D Vascular Stent System across the United Kingdom. The stent is designed to promote elevating wall shear and swirling flow and impart a natural curvature to the diseased femoropopliteal artery. Through this, the company aims to expand its product offerings in the country and improve the lives of patients living with peripheral vascular diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
|Headquarters:||Basingstoke, United Kingdom|
Blatchford Limited is a leading medical device and instrument manufacturer. The company offers innovative function, mobility, cosmesis, and comfort solutions to patients after pathological procedures or amputations. With over 1000 employees, the company has manufactured some of the most advanced prosthetic technology and aims to develop solutions that provide enhanced comfortability and precision to patients.
|Headquarters:||Maryland, United States|
Vandstrom, Inc. is a nanotechnology company that provides protein separation solutions and high-performance membranes. Through its vertical focus, nimble structure, and state-of-the-art facility, the company provides value and innovative and high-efficiency separation solutions to consumers. The company aims to enhance the quality of life and industrial operations by harnessing the capabilities of separation science.
|Headquarters:||Horsham, United Kingdom|
Veryan Medical Limited is a company owned by Otsuka Medical Devices that is engaged in the development of innovative devices deployed in peripheral intervener procedures. The company is a pioneer in developing catheter-based and minimally-invasive technologies utilised by cardiologists, radiologists, as well as vascular surgeons. In April 2021, the company announced a multimillion Euros investment at its Galway facility to expand and diversify its product portfolio.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.